Servier is an independent international pharmaceutical company that is deeply committed to innovation and improving patient lives. With its governance rooted in a non-profit foundation, Servier is uniquely positioned to prioritize patients and science.
The Golden Ticket program, sponsored by Servier in partnership with BioLabs, awards one early-stage startup lab space and other critical resources to accelerate its research and development efforts, particularly in oncology, neuroscience, and technological tools for drug discovery. The winner gains not just physical resources within Spartners by Servier & BioLabs but also access to Servier's vast network of scientific expertise and mentorship, significantly aiding in the development of novel therapies for unmet medical needs.
Application Process
The official application process can be found below. Please read and verify your availability before submitting your application.
Golden Ticket Benefits
FREE residency for 1-year including membership, lab bench and office space
to de-risk your technology and scale your business
A buzzing community
of entrepreneurs
connecting startups to local orgs and investors
A no strings
attached model
to maintain complete ownership of your IP
.png)
Possibility of access to On-demand mentoring from Servier experts on specific topic
Gateway to a
potential collaboration
with Servier a leading pharma partner
Eligibility Snapshot
Servier is looking for biotech companies working on research and development in the following areas:
Oncology
Preferentially in GastroIntestinal cancers, Glioma and rare brain cancers, hematological cancers and with cell targeting therapies or Immuno-oncology
Neuroscience
Medicines that slow the progression of rare and chronic diseases.
Drug discovery technological tools/platforms
Applicants must be:
An early-stage life science startup located in France and formed under French law.
Be able to move into Spartners shortly after winning, subject to availability.
Be comfortable working in a shared lab facility.
The Application Process
01
Submit the online application by November 20, 2026
02
A subset of applications will be identified as finalist by the contest judges by
December 14, 2026
03
Winning teams will present their company & scientific concept at an in-person event on
Jan 14, 2027
04
One award will be granted.
Good luck!
Judging Criteria and Judges
Applications go through an initial screening. Finalists pitch to a selection committee of Servier and BioLabs leadership and investors, who assess:
-
Commitment to addressing global health challenges
-
Unmet need to be addressed and potential of the envisioned product will differentiate from existing treatment options
-
Quality and impact of previously generated scientific data
-
Research plan robustness and key milestone(s) to reach within one year
-
Team competency
-
Potential to successfully achieve research milestones and downstream program maturation
-
Fit with BioLabs and Spartners membership criteria
-
Readiness to move into Spartners shortly after winning (subject to availability)
Contact Us
